Camillo Ricordi, MD, PhD
Professor and Director of the Diabetes Research Institute and the Cell Transplant Center at the University of Miami, Florida.
He is inventor of the method to isolate insulin-producing cells from the pancreas, which led to successful transplantation to reverse diabetes. The procedure is now used worldwide.
Ricordi’s research interests include reversal of autoimmunity, transplant tolerance, modulation of inflammation and regenerative medicine to prevent disease, and to prolong healthy lifespan (Healthspan).
In 2020 he lead the international team that successfully completed the first FDA approved controlled trial to treat the most severe cases of COVID-19 with stem cell infusions. The unprecedented results allowed for 100% patient survival at one month in subjects treated who were less than 85 year old, compared to 42% survival in the control group.
Ricordi and his collaborators have recently launched the program www.fit4pandemic.com to help the general population to prevent disease progression of the most severe forms of viral, autoimmune and age-related conditions, to prolong healthy lifespan (Healthspan).
He received over 100 honors and awards including the World Prize in Surgery (Geneva, CH) and the Outstanding Scientific Achievement Award (American Diabetes Association). He was Knighted by the President of Italy, inducted into the National Academy of Inventors USA, and was appointed to the Italian Supreme Council of Health.
Ricordi is author of over 1,150 scientific publications that have been cited over 45,700 times. His H-index is 102 and as an inventor, he has been awarded 27 patents.
Professor Artur Tadeusz Bossowski, MD, PhD
Head of Department of Pediatrics, Endocrinology, Diabetology with Subdivision of Cardiology in Bialystok (UMB) since October 2009.
Since 2011, he has been a Belvedere professor appointed by the President of Poland, and since 2019 an ordinary professor approved by the UMB Senate.
He is a specialist in pediatrics, endocrinology, diabetology and endocrinology and pediatric diabetology, and has also completed a specialization in pediatric cardiology.
Serves as Vice-Chairman of the Council of Clinicians and a member of the Commission for Postgraduate Education at UDSK in Bialystok.
He is a lecturer and member of the presidium of the Committee for Human Development PAN in the section of developmental age. He also serves as a provincial consultant in pediatric endocrinology and diabetes. He is also a head of specialization of three pediatricians and 8 specialists in endocrinology and pediatric diabetology.
In the years 2009-2017 he was a member (two terms) of the main board of the Polish Society of Endocrinology and Pediatric Diabetology. On behalf of the Society he acted as a coordinator of multicenter clinical trials in the field of pediatric endocrinology and diabetology in the country (conducts cooperation in immunogenetic research in selected endocrinopathies in children and within the project Strategmed-Cell therapy of diabetes type 1 based on the multiplication of artificially controlled lymphocytes CD4+CD2 5+CD127- and anti-CD20 antibody-randomised trial), as well as scientific cooperation with European centres (participates in a European project on the identification of mutations in the IGF-1 receptor in low-growth patients and thyroid dysfunction in newborns and infants of mothers with autoimmune thyroid diseases).
He participates in postgraduate education (courses and internships) organized by the Medical Center of Postgraduate Education in Warsaw (CMKP) in pediatrics, endocrinology and pediatric diabetology. He teaches pre- and attestation courses at the Child Health Center (IP CZD) in Warsaw as part of the CMKP in the field of pediatric endocrinology, and in UDSK in Bialystok in pediatrics.
For many years a visiting professor at Queen Mary University of London, Royal London Hospital, UK and a visiting professor at FIRS Laboratories RSR in Cardiff, UK.
He initiated a series of pediatric endocrine-diabetes workshops aimed at family doctors, pediatricians, internists, diabetics and endocrinologists from podlaskie province.
Since 2009, remains an active member of the Coordinator team for growth hormone treatment at the Child Health Center (IP CZD) in Warsaw.
In 2017, he received the TOP IF Award for 2016 from the Rector of the UMB. In 2018, he detected the expression of zinc transporter ZnT8 within thyroid follicular cells and C cells in postoperative thyroid tissues in children based on WB, IF and RT-PCR-as a novel autoantigen.
In the years 2001-2018 he was awarded ten times and three times awarded the Tomasz Romer Prize by the Polish Society of Endocrinology and Pediatric Diabetology for the best works in the field of pediatric endocrinology published in peer-reviewed world magazines (Pediatrics, Journal Endocrinological Investigation, Autoimmunity, Hormone Research).
In the years 2001-2018 he was awarded many times for his scientific achievements with team awards of the 1st, 2nd and 3rd degree of His Magnificence of the Rector of the UMB. In 2006, he received the Team Award of the Minister of Health for a series of 6 works on pathogenic factors in selected endocrynopathies in children, adolescents and adults in terms of immune-metabolic disorders.
Since January 2019 - the coordinator of the nationwide screening program for early detection of type 1 diabetes in families with the condition.
Project coordinator of the European Tyreological Society "Assessments of p/thyroid antibodies in newborns and infants of mothers with autoimmune thyroid disease during pregnancy". Cooperation with FIRS RSR Lab. Cardiff, UK.
In 2020 he won the KIDS competition for the best telemetry project in Poland in children with arrhythmias.
Participation in projects:
- Strategmed- "Cell therapy of type 1 diabetes based on artificially induced proliferation of CD4+CD25+CD127- regulatory lymphocytes and anti-CD20 antibody- randomized study" in cooperation with the Department of Clinical Immunology and the Department of Pediatrics, Endocrinology and Diabetology of the Medical University of Gdansk
- In 2003-2005, project leader KBN no.3PO5E00525 - "Evaluation of selected lymphocyte subpopulations, intracellular cytokines, adhesion and costimulation molecules and selected epitopes of human thyroperoxidase in tissue material from children and adolescents with thyroid diseases of developmental age”.
- In 2010-14, co-organizer of research project no.N N407 14463, funded by the MNiSzW, entitled ''Impact of biological treatment on selected biochemical and ultrasound markers of the preclinical phase of the atherosclerotic process in children with juvenile idiopathic arthritis” and in 2011-2014 - the project manager approved by the National Science Centre (NCN) (no.N N407 216640) entitled "Analysis of apoptosis, number and function of regulatory T cells in the pathogenesis of autoimmune thyroid disorders of developmental age.
- On behalf of PTEiDD - coordinator of standard-setting in thyrology of developmental age.
Agata Przemysława Chobot, MD, PhD
Head of the Department of Pediatrics of the Faculty of Medicine of the University of Opole.
A graduate of the Faculty of Medicine of the Medical University of Silesia in Katowice. She received her Doctor of Medicine degree in 2010 and her Doctor of Medicine degree in 2017. She defended her doctoral thesis at the Medical University of Warsaw on "Type 1 diabetes in pediatric population - its consequences, associated diseases and epidemiological and social aspects". Specialist in Pediatric Gastroenterology and Pediatrics.
She has completed numerous scientific internships and courses in national and foreign prestigious university centres, such as: ISPAD Physician Research School, Joslin Diabetes Center, Harvard Medical School, Boston (USA), University of Miami Miller School of Medicine (USA), Black Forest-Baar Clinic Villingen-Schwenningen (Germany), Salamanca, University of Salamanca (Spain), Leicester, Leicester Royal Infirmary (UK).
Author of 43 publications in national and international journals and 4 chapters in the book (IF: 84,6; Hirsh Index: 9 (Scopus)) on diabetology and pediatric gastroenterology. Lecturer at national and foreign scientific conferences on topics related to diabetes and pediatric gastroenterology.
In 2014-2016 she was project manager of the MNiSW grant "Iuventus Puls" (IP2012 007672): "Evaluation of the incidence of Helicobacter pylori infection in children with type 1 diabetes".
Additional scientific activities:
Membership of scientific organisations and societies:
since 2017
- Polish Society of Gastroenterology, Hepatology and Nutrition of Children
since 2010
- International Society of Pediatric and Adolescent Diabetes ISPAD - (since 2016 member of JENIOUS, a group of young scientists belonging to ISPAD; from 2021 – JENIOUS Leader)
- Polish Paediatric Society
- Polish Diabetes Society
| 2018-2020 | Reviewer of publications for the journals: International Journal of Chronic Diseases, Polish Achieves of Internal Medicine, Pediatric Diabetes |
| 2015-2018 | Ad auxiliary care of the Student Scientific Circle at the Clinic of Pediatric Diabetology of the Silesian Medical University in Katowice |
| 2016-2019 | Assistant supervisor of doctoral dissertation of Katarzyna Górowska-Kowolik - defense at the Faculty of Medicine with Dentistry Department in Zabrze of Medical University of Silesia in Katowice with distinction in 2019 |
| 2015-2017 | Assistant supervisor of doctoral dissertation of Agnieszka Szymlak - defense at the Faculty of Medicine with the Division of Dentistry in Zabrze, Silesian Medical University |
Kamil Chwojnicki, MD, PhD
Deputy Dean of the Faculty of Medicine of the Medical University of Gdańsk. Assistant Professor at the Department of Anaesthesiology and Intensive Care, Medical University of Gdańsk.
He specializes in neurological diseases.
A graduate of the Medical University of Gdansk. In 2001-2002 he was a scholarship holder of the Socrates-Erasmus programme at the Claude Bernard University in Lyon. After returning to Gdansk he became an employee of the Department of Adult Neurology. In 2008 he gained a doctoral degree in medical sciences and defended his doctoral thesis entitled "Quality assessment of secondary prevention after ischemic stroke in a representative sample of Gdynia residents". He became a habilitated doctor in 2018.
Participant of numerous foreign scholarships and courses, especially in the field of treatment and prevention of ischemic stroke. He is a co-author of about 100 scientific publications, conference reports and chapters in textbooks.
He also cooperated with the Pomeranian Marshal's Office implementing programs to improve stroke monitoring and prevention in the region. He has been a lecturer in courses for neurologists, family doctors and anesthesiologists.
Professor Przemysława Jarosz-Chobot MD, PhD
Head of Department of Pediatrics, Diabetology Clinic, Medical Faculty of the Medical University of Silesia in Katowice.
From 2010 to 2019 provincial consultant in diabetology and from 2019 provincial consultant in pediatric endocrinology and diabetology for the Province of Silesia. Since 2016 Member of the Task Force of the Polish Academy of Sciences PAN on the evaluation of diabetes epidemiology in Poland and the quality of public statistics. Since 2019 she is a Member of the Polish Academy of Sciences, on the Human Development Committee.
She is a graduate of the Medical University of Silesia. She has completed numerous scientific internships and courses in prestigious national and international diabetology centres, e. g. Erasmus University of Rotterdam (the Netherlands), WHO Epidemiological Course Cambridge (United Kingdom), Wright University, Dayton (USA). She works in many national and international scientific groups (e. g. EUCADET - European Children and Adolescent Diabetes and Endocrine Trials network, Hvidøre Study Group). She was and is a contractor of many national and international scientific grants (e. g. NCBiR STRATEGMED TREGS, EURODIAB, EUBIROD, INTERPRET, INNODIA).
Lecturer at national and international scientific congresses, courses, workshops. Author of over several hundred scientific publications and numerous popular and educational materials for diabetic patients.
National scientific programmes:
1999-2002 KBN 4PO5EO73/8 Selected genetic markers in children with type 1 diabetes and members of their families in the population of Upper Silesia (main investigator)
2000-2001 Batory Foudation 18399/99/WB/W "Developmental Diabetes and Endocrinology on the Internet (project leader)
2004-2004 PB2/KBN/040/P04/08 interuniversity (Institute of Oncology, University of Silesia, Silesian University of Technology, Medical University of Silesia), Application of modern functional genomics methods to solve important problems in biotechnology and medicine (main investigator)
2005-2008 National Programme of the Great Orchestra of Christmas Charity Foundation (WOŚP) -Evaluation of insulin pump therapy for the youngest children with diabetes (main contractor)
2005-2008 KBN 3 T11F010 „Bioinformatic methods for identification of genetic and environmental risk factors for major autoimmune diseases of the endocrine glands" (main contractor)
2008-2010 KBN 407 022535 Population variation of the glucokinase (GCK) gene in the pathogenesis and clinical course of diabetes (principal investigator)
2008-2010 KBN-6-347/08: Evaluation of the role of selected genetic factors and endothelial function in the development of hypertension in children with type 1 diabetes (project manager)
2010-2013 KBNN519 579938 New bioinformatics methods for studying genetic diseases of complex inheritance type (main contractor) UM Łódź
2014-2015 IP2010 004770 Psychiatric problems in pediatric patients with type 1 diabetes - influence on treatment effects, metabolic control and quality of life UM Łódź
2015-2016 Influence of FTO gene polymorphism on the effects of empowerment-type psychotherapy in adolescent girls with type 1 diabetes (main investigator), UM Białystok
2015- 2018 NCBiR STRATEGMED TREGS Cell therapy based on artificially propagated regulatory lymphocytes, the consortium of SUM Katowice, UM of Lodz, UM of Bialystok and UM of Rzeszow (main contractor)
International scientific programmes (main scientist; selected):
1999- nadal EURODIAB - Epidemiology of Type 1 Diabetes Mellitus in Europe (grant EU 1989-1998)
2002- 2019 TRIGR - Trial to Reduce IDDM in the Genetically At Risk (koordynator regionalny, grant NIH)
2003, 2005 PedPumpStudy PPSG European Pediatric Pump Survey, Round 2 i 3
2003-2008 EUCID– EU - European Core Indicators in Diabetes (grant EU)
2008-2011 EUBIROD-EU - European Best Indicators through Regional Outcomes Diabetes (grant EU)
2009-2011 OCAPI - European post-marketing observational prospective cohort study of children with type 1 diabetes treated with Apidra (koordynator krajowy)
2009-2011 INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy
2009- nadal The Hvidøre Study Group on Childhood Diabetes
2015- nadal INNODIA Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM) (grant EU)
- -2020 Medtronic “ Usefulness evaluation of CGMS in analyzing and preveting hyper hypoglycemia fluction cardic surgery patients at perioperative perios treated in Cardic Surgery Intensive Care Unit”
103 papers were cited in 1486 publications, Hirsch index: 18 in Web of Science Core Collection and Scopus database respectively.
Co-author of published international and national guidelines
- ISPAD Consensus Guidelines 2000, 2009, 2014 and 2018 their Polish editions (Practical Medicine - Pediatrics 2001, 2010, 2015) and IDF 2012- PTD clinical recommendations for the management of patients with diabetes, published annually (2005-still)
- Committee on Standards for the Treatment of Children with Insulin Pumps, Common Position: ADA (American Diabetes Association), EASD (European Association for the Study of Dia betes), ESPE (European Society of Pediatrics Endocrinology), ISPAD (International Society for Pediatric & Adolescent Diabetes) i LWPES (Lawson Wilkins Pediatric Endocrine Society – Diabetes Care 2007;30,6,1653-1662).
Professor Iwona Kurkowska-Jastrzębska MD, PhD
Head of the Second Neurological Clinic at the Institute of Psychiatry and Neurology in Warsaw.
The main scientific and research interests concern neuroimmunology, especially the interaction of the immune and nervous systems, inflammatory diseases (multiple sclerosis, autoimmune encephalitis, paraneoplastic syndromes) and the participation of the inflammatory response in the pathogenesis of diseases of the nervous system (neurodegenerative diseases and epilepsy).
Recently, she has conducted research on the search for protein biomarkers in epilepsy. She conducts both basic and clinical research in cooperation with the Department of Pharmacology of the Medical University of Warsaw.
For more than 10 years she has participated in commercial and academic clinical trials as a contractor and as a head cotractor on epilepsy, multiple sclerosis and stroke.
Currently she is coordinating a non-commercial clinical trial in Poland PRECIOUS: Prevention of complications to improve prognosis in elderly patients with acute stroke, funded by the HORIZON 2020 programme.
Professor Wojciech Młynarski MD, PhD
Head of the Department of Paediatrics, Oncology and Haematology of Medical University of Lodz.
He is a pediatric specialist, pediatric oncologist and hematologist, and pediatric endocrinologist and diabetologist. Apart from his scientific work, his main clinical interests include rational management of life-threatening conditions in paediatrics and molecular diagnostics and treatment in rare diseases in children.
A graduate of the Faculty of Biology and Earth Sciences at the University of Lodz (major: molecular biology) and the Faculty of Medicine at the Medical University of Lodz (medical doctor). He was awarded the degree of Doctor of Medicine in 2000 and the degree of Habilitated Doctor in 2004. In 2007 he was awarded the title of Professor by the President of the Republic of Poland, Lech Kaczyński and became the Head of the Department of the Medical University of Lodz. From 2002 to 2004, he was a postdoctoral research fellow in the Department of Genetics and Epidemiology, Joslin Diabetes Center, Harvard Medical School, Boston. In the years 2004-2008 he held further scientific internships in the USA as a visiting researcher affiliated with Harvard Medical School.
Since 2019, he has been the leader of the TEAM-NET project funded by the Foundation for Polish Science aimed at creating an innovative diagnostic and therapeutic method in innate neutropenia using CRISP-CAS9 technology.
From 2020, he is the leader of the CALL-POL project funded by the Medical Research Agency, which aims to individualize the treatment of acute lymphoblastic leukemia in children through modern molecular diagnostics and targeted therapy.
He is a member of many scientific societies in Poland and abroad, among others he was a member of the Board of the Polish Diabetes Society and the International Society of Pediatric and Adolescent Diabetes and is currently a member of the Board and treasurer of the Polish Society of Oncology and Pediatric Hematology. He is also a member of the National Council for the Treatment of Haemophilia and Related Haemorrhagic Blemishes and the Department of Health's Rare Diseases Team.
He has authored or co-authored more than 350 scientific publications (MNiSW score >7000, IF >1000, HI33), among others in such journals as The New England Journal of Medicine, Nature Communication, Nature Chemical Biology, Nature Clinical Practice Neurology, Lancet Heamatology, Blood, Leukemia, Haematologica, Diabetes, Diabetes Care, Diabetology and Clinical Cancer Research.
Agnieszka Szadkowska MD, PhD
Assistant Professor at the Department of Pediatrics, Oncology, Hematology and Diabetology of the Medical University of Łódź. Head of Department of Paediatrics, Endocrinology, Diabetology and Nephrology, Paediatric Centre of Central Clinical Hospital in Łódź.
Specialist pediatrician, diabetologist, nephrologist, endocrinologist and pediatric diabetologist.
She is a member of the Polish Diabetological Association (PTD). Since 2016 Secretary of the PTD Main Board, Member of the Board of the Pediatric Section of the PTD, from 2008 to 2012 President of the PTD Board. He is also a member of: Polish Pediatric Society, Polish Society of Pediatric Endocrinologists and Diabetologists (since 2017 member of the Board), European Association for the Study of Diabetes, International Society for Pediatric and Adolescent Diabetes. He is also a member of the Clinical Recommendations Group for the management of diabetic patients of the Polish Diabetes Association.
She is the author of 182 original, illustrative publications, chapters in textbooks and monographs and 275 conference reports.
Manager of specialization courses, courses for educators.
Founder – founder of the “Diabeciaki” Foundation
Natalia Marek-Trzonkowska, MD, PhD
Young Investigator Award – Internation Society of Pediatric and Adolescent Diabetes (ISPAD; Istambul, Turkey), Award for research on regulatory T cells – the European Federation of Immunological Societies (EFIS), Kosciuszko Foundation scholarship for the project „Feasibility of in vitro expansion of regulatory T cells for adoptive immunotherapy of potential recipients of pancreatic Islets” (University of Chicago, USA), two prizes of The International Pancreas and Islet Transplantation Association (IPITA) and many national awards including prestigious Tomasz E. Romer award, “Golden Scalpel”.
Małgorzata Myśliwiec, MD, PhD
Co-author of the patented TREG method.
Co-founder of the PolTREG Company.
Prof. dr hab. med., Head of Department and Clinic of Pediatrics, Diabetology and Endocrinology at the Medical University of Gdansk.
Member of the Board of the Polish Diabetes Association, President of Pediatric Section of the Polish Diabetes Association.
Three prizes of Polish Society of Children Endocrinology (2006, 2011, 2012), the best paper award from the Polish Society of Parenteral and Enteral Nutrition, Prestigious Tomasz E. Romer prize for best thesis in the area of endocrinology (2006,2008), Silver Cross of Merit, “Golden Scalpel”